“One reason is that after breaking up a conglomerate into more focused operations, both parent and spin-off are more likely to become takeover targets. Over half of the companies in the Goldman Sachs study received takeover offers in the years after the demerger.”
The timing is very good from a macroeconomic perspective. I will be voting yes because I believe the value of the two seperate entities will be greater than the previous arrangement.
- Forums
- ASX - By Stock
- TOE
- Ann: Trading Halt
TOE
toro energy limited
Add to My Watchlist
2.56%
!
20.0¢

Ann: Trading Halt, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $24.05M |
Open | High | Low | Value | Volume |
19.5¢ | 20.5¢ | 19.5¢ | $62.53K | 316.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 121564 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 41011 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 121564 | 0.190 |
2 | 34000 | 0.185 |
2 | 62631 | 0.180 |
3 | 9567 | 0.175 |
1 | 29411 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 41011 | 1 |
0.205 | 8319 | 3 |
0.210 | 49756 | 3 |
0.215 | 2342 | 1 |
0.220 | 11439 | 5 |
Last trade - 15.56pm 27/06/2025 (20 minute delay) ? |
Featured News
TOE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online